Twist Bioscience shares slide 20% after short seller compares synthetic DNA provider to Theranos, calling it a 'cash-burning inferno'

Twist Bioscience Corp. stock slid 20% Tuesday, after a damning short seller report compared the company to the failed blood-testing startup Theranos,

Tuesday, November 15, 2022 at 8:44 pm

Full Coverage